ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

BGLC BioNexus Gene Lab Corporation

0.575
0.0011 (0.19%)
Pre Market
Last Updated: 07:47:20
Delayed by 15 minutes

Period:

Draw Mode:

Volume 251
Bid Price 0.575
Ask Price 0.60
News -
Day High

Low
0.31

52 Week Range

High
9.49

Day Low
Company Name Stock Ticker Symbol Market Type
BioNexus Gene Lab Corporation BGLC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0011 0.19% 0.575 07:47:20
Open Price Low Price High Price Close Price Prev Close
0.5739
Trades Volume Avg Volume 52 Week Range
5 251 - 0.31 - 9.49
Last Trade Time Type Quantity Stock Price Currency
07:47:20 formt 148 $ 0.575 USD

BioNexus Gene Lab Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
10.07M 17.67M - 10.26M -2.63M -0.15 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

BioNexus Gene Lab News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BGLC Message Board. Create One! See More Posts on BGLC Message Board See More Message Board Posts

Historical BGLC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.580.6060.550.578930976,402-0.005-0.86%
1 Month0.61820.6790.550.596995376,677-0.0432-6.99%
3 Months0.711.200.550.7990694228,565-0.135-19.01%
6 Months0.34653.390.3311.131,807,3040.228565.95%
1 Year3.509.490.311.491,920,700-2.93-83.57%
3 Years3.509.490.311.491,920,700-2.93-83.57%
5 Years3.509.490.311.491,920,700-2.93-83.57%

BioNexus Gene Lab Description

BioNexus Gene Lab Corp is an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management. It focuses on developing and marketing safe, effective, and non-invasive blood tests for the early detection of diseases. The company's non-invasive blood tests analyze changes in ribonucleic acid (or RNA) to detect the potentiality of 11 different diseases. These diseases include eight cancers (nasopharyngeal, lung, liver, stomach, breast, cervical, prostate, and colon), two bowel diseases (colitis and Crohn), and osteoarthritis.